MedPath

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy versus R0 Resection for Resectable Colorectal Cancer with Peritoneal Metastases with Low Peritoneal Cancer Index Score: A Collaborative Observational Study from Korea and Japa

Not Applicable
Conditions
Colorectal Cancer with Peritoneal Metastases
Registration Number
JPRN-UMIN000051539
Lead Sponsor
Yonsei University College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
166
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with appendiceal cancer were excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relapse-free survival (RFS), which was defined as the time from surgery for CPM to the first peritoneal or distant relapse or death from any cause.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath